Brief: BB Biotech AG Reports Net Loss Of CHF 241 Mn For Q1 2025
25/04/2025 06:06
April 25 (Reuters) - BB BIOTECH AG BION.S: REPORTS NET LOSS OF CHF 241 MN FOR Q1 2025 NAV DECLINED BY 10.8% IN CHF AND 12.3% IN EUR PORTFOLIO WAS REDUCED TO 23 POSITIONS, WITH A GROWING FOCUS ON COMPANIES ABOVE USD 1 BN IN MARKET CAPITALIZATION, REFLECTING A MORE BALANCED POSITIONING LATEST TARIFF ESCALATION UNDER TRUMP ADMINISTRATION HAS HAD MINIMAL DIRECT FUNDAMENTAL IMPACT ON OUR PORTFOLIO COMPANIES Source text: ID:nEQ3jrGk4a Further company coverage: BION.S (Gdansk Newsroom) (((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600);))